Olympus Corporation Selects Linkwell's Endoscope Disinfectant; The market size for this product in China is $8 million to $10 million per year.

FORT LAUDERDALE, Fla. -- Linkwell Corporation (OTCBB:LWLL), a leading manufacturer and distributor of disinfectant products in China, has been chosen by the Olympus Corporation to provide disinfectant and cleaning solutions. Linkwell Corporation's subsidiary, Shanghai Likang Disinfectant Co., Ltd. is a leading manufacturer and distributor of a wide variety of disinfectant products in China. The Olympus Corporation has selected a product series of Likang (Dianerkang, 2% glutaraldehyde disinfectant), as its automatic endoscope special-purpose disinfectant.

Olympus, a leading endoscope manufacturer, selected Linkwell following an extensive review of the competitive marketplace. This Linkwell product will replace products previously supplied by Johnson and Johnson, Inc. currently used by the Olympus Corporation. The present cooperation has already been progressively launched nationally in China.

Olympus Corporation, traded on the OTCPK under OCPNF manufactures a line of opto-electronic microscopes and related products. Olympus products include cameras, video sets, endoscopes, microscopes, analytical equipment, office communication systems, laser-optical scanners, and ionic printers.

Xuelian Bian, CEO and President of LWLL, commented, "The selection of our product by this industry giant demonstrates the quality of our line of disinfectant products. The market size for this product in China is $8 to $10 million per year. We believe we are going to dominate this niche for years to come. Furthermore this partnership represents a milestone in our history as we try to turn our research and development into commercial success in a much more cost effective and expeditious manner."

About Linkwell Corporation:

Linkwell Corporation is a leading developer, manufacturer, and marketing of disinfectant healthcare products in the People's Republic of China through its 90% owned subsidiary Shanghai Likang Disinfectant High Tech Company (Likang). Linkwell Corporation is a U.S. corporation headquartered in Boca Raton, Florida and is publicly traded in the OTC Bulletin Board Exchange under the symbol (OTCBB: LWLL).

Linkwell's disinfectant healthcare products are the leading and only nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectant, liquid and tablet products, as well as disinfectant instruments, devices and materials. These may also include air disinfecting machines, hot press bags, disinfection swabs and disinfection tampons. Through Likang, Linkwell is the only domestic Chinese company that has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of the People's Republic of China. All inventory and order fulfillment is carried out of a 21,500 square foot facility in Shanghai's Jiading district. The company's products have gradually made their way from medical disinfection to also include civil disinfection, industrial disinfection, and agricultural and livestock disinfection. For more info about the company please visit http://www.linkwell.us.

Safe Harbor Statement

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets.